FDA/CMS Summit

FDA/CMS Summit draws the highest leadership at the FDA to update the industry on current developments, initiatives, changes and the year ahead as it pertains to major stakeholders in the drug development process. CMS brings updates on changes to pharmaceutical coverage and other key areas of policy under its oversight. This is the only event that convenes both groups together to meet with senior and executive leadership and regulatory leaders within the industry and continues to deliver .. continue reading best available information on FDA and CMS priorities, policy changes, evidence-based practice, federal review processes on various areas of biopharma like CDER, CBER, CDRH and the most cutting-edge advances in healthcare and technology. The event is geared to the information needs of C-Suite biopharmaceutical executives, Directors/VPs of Regulatory/Government Affairs, FDA regulators, consultants, law firms, PhRMA and big pharmaceutical companies.